Raheleh Farahzadi
Tabriz University of Medical Sciences, Australia · Iran, Islamic Republic of
Editorial leadership for Journal of Evolving Stem Cell Research ISSN 2574-4372
Research interests
- Regenerative Medicine Tissue Enginering Stem Cell Therapy In Neurodegenerative Disease Stem Cell Therapy In Cardiac Therapy Cellular Signaling Multi Lineage Differentiation Of Stem Cells
Biography
Dr. Raheleh Farahzadi is affiliated with Tabriz University of Medical Sciences, Australia, where her research focuses on mesenchymal stem cell biology, aging, and regenerative medicine. She has published over 14 indexed articles, with her most-cited work, "COVID-19 infection: an overview on cytokine storm and related interventions" (2022), receiving 540 citations. Her research contributions span the modulation of stem cell aging and differentiation through interventions including L-carnitine, zinc sulphate, and electromagnetic fields, with particular emphasis on signaling pathways such as Wnt/β-catenin, PKA, and ERK1/2, as well as telomerase (TERT) gene expression in adipose-derived mesenchymal stem cells. Dr. Farahzadi achieved first top grade in the Ph.D. entrance examination, reflecting her academic distinction in the field of stem cell research and cellular therapeutics.
Selected publications
- COVID-19 infection: an overview on cytokine storm and related interventions 2022 cited 540×
- Cytokines secreted from bone marrow derived mesenchymal stem cells promote apoptosis and change cell cycle distribution of K562 cell line as clinical agent in cell transplantation 2019 cited 56×
- Silver nanoparticles induce the cardiomyogenic differentiation of bone marrow derived mesenchymal stem cells via telomere length extension 2021 cited 50×
- Granulocyte differentiation of rat bone marrow resident C-kit+ hematopoietic stem cells induced by mesenchymal stem cells could be considered as new option in cell-based therapy 2023 cited 45×
- Cardiac differentiation of bone-marrow-resident c-kit+ stem cells by L-carnitine increases through secretion of VEGF, IL6, IGF-1, and TGF-β as clinical agents in cardiac regeneration 2020 cited 43×
- Interleukin-6, -8, and TGF-β Secreted from Mesenchymal Stem Cells Show Functional Role in Reduction of Telomerase Activity of Leukemia Cell Via Wnt5a/β-Catenin and P53 Pathways 2020 cited 39×
Ranked by citation impact (Crossref) where available, newest otherwise · verified via ORCID.
Considering JESR for your work?
This journal is guided by Raheleh Farahzadi (Tabriz University of Medical Sciences, Australia) and a peer-review board of practising researchers. Open access, author-retained copyright (CC BY), and a clear editorial process.